HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Oligonol Ameliorates CCl₄-Induced Liver Injury in Rats via the NF-Kappa B and MAPK Signaling Pathways.

Abstract
Oxidative stress is thought to be a key risk factor in the development of hepatic diseases. Blocking or retarding the reactions of oxidation and the inflammatory process by antioxidants could be a promising therapeutic intervention for prevention or treatment of liver injuries. Oligonol is a low molecular weight polyphenol containing catechin-type monomers and oligomers derived from lychee fruit. In this study, we investigated the anti-inflammatory effect of oligonol on carbon tetrachloride- (CCl4-) induced acute hepatic injury in rats. Oral administration of oligonol (10 or 50 mg/kg) reduced CCl4-induced abnormalities in liver histology and serum AST and serum ALT levels. Oligonol treatment attenuated the CCl4-induced production of inflammatory mediators, including TNF-α, IL-1β, cyclooxygenase-2 (COX-2), and inducible nitric oxide synthase (iNOS) mRNA levels. Western blot analysis showed that oligonol suppressed proinflammatory nuclear factor-kappa B (NF-κB) p65 activation, phosphorylation of extracellular signal-regulated kinase (ERK), c-Jun NH2-terminal kinase (JNK), and p38 mitogen-activated protein kinases (MAPKs) as well as Akt. Oligonol exhibited strong antioxidative activity in vitro and in vivo, and hepatoprotective activity against t-butyl hydroperoxide-induced HepG2 cells. Taken together, oligonol showed antioxidative and anti-inflammatory effects in CCl4-intoxicated rats by inhibiting oxidative stress and NF-κB activation via blockade of the activation of upstream kinases including MAPKs and Akt.
AuthorsJeonghyeon Bak, Nam Kyung Je, Hae Young Chung, Takako Yokozawa, Sik Yoon, Jeon-Ok Moon
JournalOxidative medicine and cellular longevity (Oxid Med Cell Longev) Vol. 2016 Pg. 3935841 ( 2016) ISSN: 1942-0994 [Electronic] United States
PMID26798422 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Antioxidants
  • Biphenyl Compounds
  • Ferrous Compounds
  • Interleukin-1beta
  • NF-kappa B
  • Phenols
  • Picrates
  • Tumor Necrosis Factor-alpha
  • oligonol
  • ferrous sulfate
  • Malondialdehyde
  • Catechin
  • tert-Butylhydroperoxide
  • Hydrogen Peroxide
  • Carbon Tetrachloride
  • 1,1-diphenyl-2-picrylhydrazyl
  • Nitric Oxide Synthase Type II
  • Cyclooxygenase 2
  • PTGS2 protein, human
  • Aspartate Aminotransferases
  • Alanine Transaminase
  • Proto-Oncogene Proteins c-akt
Topics
  • Alanine Transaminase (blood)
  • Animals
  • Antioxidants (pharmacology, therapeutic use)
  • Aspartate Aminotransferases (blood)
  • Biphenyl Compounds (chemistry)
  • Carbon Tetrachloride
  • Catechin (analogs & derivatives, pharmacology, therapeutic use)
  • Cell Nucleus (drug effects, metabolism)
  • Cyclooxygenase 2 (metabolism)
  • Enzyme Activation (drug effects)
  • Ferrous Compounds (toxicity)
  • Gene Expression Regulation (drug effects)
  • Hep G2 Cells
  • Humans
  • Hydrogen Peroxide (toxicity)
  • Interleukin-1beta (genetics, metabolism)
  • Lipid Peroxidation (drug effects)
  • Liver (drug effects, pathology)
  • Liver Diseases (blood, drug therapy, enzymology, genetics)
  • MAP Kinase Signaling System (drug effects)
  • Malondialdehyde (metabolism)
  • NF-kappa B (metabolism)
  • Nitric Oxide Synthase Type II (genetics, metabolism)
  • Phenols (pharmacology, therapeutic use)
  • Picrates (chemistry)
  • Protein Transport (drug effects)
  • Proto-Oncogene Proteins c-akt (metabolism)
  • Rats, Sprague-Dawley
  • Tumor Necrosis Factor-alpha (genetics, metabolism)
  • tert-Butylhydroperoxide

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: